These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. Touloumi G; Pantazis N; Pillay D; Paraskevis D; Chaix ML; Bucher HC; Kücherer C; Zangerle R; Kran AM; Porter K; Clin Infect Dis; 2013 Mar; 56(6):888-97. PubMed ID: 23223594 [TBL] [Abstract][Full Text] [Related]
8. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. Reekie J; Gatell JM; Yust I; Bakowska E; Rakhmanova A; Losso M; Krasnov M; Francioli P; Kowalska JD; Mocroft A; AIDS; 2011 Nov; 25(18):2259-68. PubMed ID: 21918422 [TBL] [Abstract][Full Text] [Related]
9. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851 [TBL] [Abstract][Full Text] [Related]
10. Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon? Madec Y; Boufassa F; Rouzioux C; Delfraissy JF; Meyer L; Clin Infect Dis; 2005 May; 40(9):1350-4. PubMed ID: 15825038 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. Pedersen C; Katzenstein T; Nielsen C; Lundgren JD; Gerstoft J J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):93-9. PubMed ID: 9358103 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215 [TBL] [Abstract][Full Text] [Related]
13. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. Hubert JB; Burgard M; Dussaix E; Tamalet C; Deveau C; Le Chenadec J; Chaix ML; Marchadier E; Vildé JL; Delfraissy JF; Meyer L; Rouzioux AIDS; 2000 Jan; 14(2):123-31. PubMed ID: 10708282 [TBL] [Abstract][Full Text] [Related]
14. Effect of influenza vaccination on disease progression among HIV-infected persons. Sullivan PS; Hanson DL; Dworkin MS; Jones JL; Ward JW; AIDS; 2000 Dec; 14(17):2781-5. PubMed ID: 11125897 [TBL] [Abstract][Full Text] [Related]
15. Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials. Buchacz K; Hu DJ; Vanichseni S; Mock PA; Chaowanachan T; Srisuwanvilai LO; Gvetadze R; Van Griensven F; Tappero JW; Kitayaporn D; Kaewkungwal J; Choopanya K; Mastro TD J Acquir Immune Defic Syndr; 2004 Jul; 36(3):853-60. PubMed ID: 15213570 [TBL] [Abstract][Full Text] [Related]